Copyright Reports & Markets. All rights reserved.

Global Dry Powder Inhaler Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Dry Powder Inhaler

      • 1.1 Definition of Dry Powder Inhaler
      • 1.2 Dry Powder Inhaler Segment by Type
        • 1.2.1 Global Dry Powder Inhaler Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Single Dose Dry Powder Inhaler
        • 1.2.3 Multi Dose Dry Powder Inhaler
      • 1.3 Dry Powder Inhaler Segment by Applications
        • 1.3.1 Global Dry Powder Inhaler Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Asthma
        • 1.3.3 Chronic Obstructive Pulmonary Disease
        • 1.3.4 Pulmonary Arterial Hypertension
        • 1.3.5 Others
      • 1.4 Global Dry Powder Inhaler Overall Market
        • 1.4.1 Global Dry Powder Inhaler Revenue (2014-2025)
        • 1.4.2 Global Dry Powder Inhaler Production (2014-2025)
        • 1.4.3 North America Dry Powder Inhaler Status and Prospect (2014-2025)
        • 1.4.4 Europe Dry Powder Inhaler Status and Prospect (2014-2025)
        • 1.4.5 China Dry Powder Inhaler Status and Prospect (2014-2025)
        • 1.4.6 Japan Dry Powder Inhaler Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Dry Powder Inhaler Status and Prospect (2014-2025)
        • 1.4.8 India Dry Powder Inhaler Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Dry Powder Inhaler
      • 2.3 Manufacturing Process Analysis of Dry Powder Inhaler
      • 2.4 Industry Chain Structure of Dry Powder Inhaler

      3 Development and Manufacturing Plants Analysis of Dry Powder Inhaler

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Dry Powder Inhaler Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Dry Powder Inhaler
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Dry Powder Inhaler Production and Capacity Analysis
      • 4.2 Dry Powder Inhaler Revenue Analysis
      • 4.3 Dry Powder Inhaler Price Analysis
      • 4.4 Market Concentration Degree

      5 Dry Powder Inhaler Regional Market Analysis

      • 5.1 Dry Powder Inhaler Production by Regions
        • 5.1.1 Global Dry Powder Inhaler Production by Regions
        • 5.1.2 Global Dry Powder Inhaler Revenue by Regions
      • 5.2 Dry Powder Inhaler Consumption by Regions
      • 5.3 North America Dry Powder Inhaler Market Analysis
        • 5.3.1 North America Dry Powder Inhaler Production
        • 5.3.2 North America Dry Powder Inhaler Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Dry Powder Inhaler Import and Export
      • 5.4 Europe Dry Powder Inhaler Market Analysis
        • 5.4.1 Europe Dry Powder Inhaler Production
        • 5.4.2 Europe Dry Powder Inhaler Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Dry Powder Inhaler Import and Export
      • 5.5 China Dry Powder Inhaler Market Analysis
        • 5.5.1 China Dry Powder Inhaler Production
        • 5.5.2 China Dry Powder Inhaler Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Dry Powder Inhaler Import and Export
      • 5.6 Japan Dry Powder Inhaler Market Analysis
        • 5.6.1 Japan Dry Powder Inhaler Production
        • 5.6.2 Japan Dry Powder Inhaler Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Dry Powder Inhaler Import and Export
      • 5.7 Southeast Asia Dry Powder Inhaler Market Analysis
        • 5.7.1 Southeast Asia Dry Powder Inhaler Production
        • 5.7.2 Southeast Asia Dry Powder Inhaler Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Dry Powder Inhaler Import and Export
      • 5.8 India Dry Powder Inhaler Market Analysis
        • 5.8.1 India Dry Powder Inhaler Production
        • 5.8.2 India Dry Powder Inhaler Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Dry Powder Inhaler Import and Export

      6 Dry Powder Inhaler Segment Market Analysis (by Type)

      • 6.1 Global Dry Powder Inhaler Production by Type
      • 6.2 Global Dry Powder Inhaler Revenue by Type
      • 6.3 Dry Powder Inhaler Price by Type

      7 Dry Powder Inhaler Segment Market Analysis (by Application)

      • 7.1 Global Dry Powder Inhaler Consumption by Application
      • 7.2 Global Dry Powder Inhaler Consumption Market Share by Application (2014-2019)

      8 Dry Powder Inhaler Major Manufacturers Analysis

      • 8.1 Astrazeneca
        • 8.1.1 Astrazeneca Dry Powder Inhaler Production Sites and Area Served
        • 8.1.2 Astrazeneca Product Introduction, Application and Specification
        • 8.1.3 Astrazeneca Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 3M
        • 8.2.1 3M Dry Powder Inhaler Production Sites and Area Served
        • 8.2.2 3M Product Introduction, Application and Specification
        • 8.2.3 3M Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GlaxoSmithKline
        • 8.3.1 GlaxoSmithKline Dry Powder Inhaler Production Sites and Area Served
        • 8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.3.3 GlaxoSmithKline Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Dry Powder Inhaler Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Cipla
        • 8.5.1 Cipla Dry Powder Inhaler Production Sites and Area Served
        • 8.5.2 Cipla Product Introduction, Application and Specification
        • 8.5.3 Cipla Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Teva
        • 8.6.1 Teva Dry Powder Inhaler Production Sites and Area Served
        • 8.6.2 Teva Product Introduction, Application and Specification
        • 8.6.3 Teva Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Boehringer Ingelheim
        • 8.7.1 Boehringer Ingelheim Dry Powder Inhaler Production Sites and Area Served
        • 8.7.2 Boehringer Ingelheim Product Introduction, Application and Specification
        • 8.7.3 Boehringer Ingelheim Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Chiesi Farmaceutici
        • 8.8.1 Chiesi Farmaceutici Dry Powder Inhaler Production Sites and Area Served
        • 8.8.2 Chiesi Farmaceutici Product Introduction, Application and Specification
        • 8.8.3 Chiesi Farmaceutici Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 MannKind
        • 8.9.1 MannKind Dry Powder Inhaler Production Sites and Area Served
        • 8.9.2 MannKind Product Introduction, Application and Specification
        • 8.9.3 MannKind Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Vectura
        • 8.10.1 Vectura Dry Powder Inhaler Production Sites and Area Served
        • 8.10.2 Vectura Product Introduction, Application and Specification
        • 8.10.3 Vectura Dry Powder Inhaler Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Dry Powder Inhaler Market

      • 9.1 Global Dry Powder Inhaler Market Trend Analysis
        • 9.1.1 Global Dry Powder Inhaler Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Dry Powder Inhaler Regional Market Trend
        • 9.2.1 North America Dry Powder Inhaler Forecast 2019-2025
        • 9.2.2 Europe Dry Powder Inhaler Forecast 2019-2025
        • 9.2.3 China Dry Powder Inhaler Forecast 2019-2025
        • 9.2.4 Japan Dry Powder Inhaler Forecast 2019-2025
        • 9.2.5 Southeast Asia Dry Powder Inhaler Forecast 2019-2025
        • 9.2.6 India Dry Powder Inhaler Forecast 2019-2025
      • 9.3 Dry Powder Inhaler Market Trend (Product Type)
      • 9.4 Dry Powder Inhaler Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Dry Powder Inhaler Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus. DPIs are an alternative to the aerosol-based inhalers commonly called metered-dose inhaler (or MDI).
        Chronic obstructive pulmonary disease will continue to be the fast-expanding application of dry powder inhalers.

        The global Dry Powder Inhaler market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Dry Powder Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dry Powder Inhaler market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Dry Powder Inhaler in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Dry Powder Inhaler manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Astrazeneca
        3M
        GlaxoSmithKline
        Novartis
        Cipla
        Teva
        Boehringer Ingelheim
        Chiesi Farmaceutici
        MannKind
        Vectura

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Single Dose Dry Powder Inhaler
        Multi Dose Dry Powder Inhaler

        Segment by Application
        Asthma
        Chronic Obstructive Pulmonary Disease
        Pulmonary Arterial Hypertension
        Others

        Buy now